2017
DOI: 10.1080/1040841x.2017.1329274
|View full text |Cite
|
Sign up to set email alerts
|

NontypeableHaemophilus influenzaeand chronic obstructive pulmonary disease: a review for clinicians

Abstract: Chronic Obstructive Pulmonary Disease (COPD) is a leading cause of morbidity and mortality worldwide. In the lower airways of COPD patients, bacterial infection is a common phenomenon and Haemophilus influenzae is the most commonly identified bacteria. Haemophilus influenzae is divided into typeable and nontypeable (NTHi) strains based on the presence or absence of a polysaccharide capsule. While NTHi is a common commensal in the human nasopharynx, it is associated with considerable inflammation when it is pre… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
34
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 39 publications
(34 citation statements)
references
References 186 publications
0
34
0
Order By: Relevance
“…While nontypeable Haemophilus influenzae (NTHi) is a common commensal of the human nasopharynx, this bacterium is also associated with a spectrum of diseases including otitis media and sinusitis, as well as hospital-and community-acquired pneumonia [1]. In addition, NTHi is the most common bacterial cause of chronic obstructive pulmonary disease (COPD) exacerbations [2][3][4]. NTHi has developed mechanisms to thrive in the hostile environment of different anatomical regions, such as the middle ear, upper and lower respiratory tracts, blood and the meninges [5].…”
Section: Introductionmentioning
confidence: 99%
“…While nontypeable Haemophilus influenzae (NTHi) is a common commensal of the human nasopharynx, this bacterium is also associated with a spectrum of diseases including otitis media and sinusitis, as well as hospital-and community-acquired pneumonia [1]. In addition, NTHi is the most common bacterial cause of chronic obstructive pulmonary disease (COPD) exacerbations [2][3][4]. NTHi has developed mechanisms to thrive in the hostile environment of different anatomical regions, such as the middle ear, upper and lower respiratory tracts, blood and the meninges [5].…”
Section: Introductionmentioning
confidence: 99%
“…There are currently no effective vaccination strategies for the prevention of NTHi infections, and treatment has been complicated by the rapid development of antibiotic resistance to first-and second-line antibiotics. Resistance is predominantly mediated by β-lactamase production [7]; however, the emergence and spread of β-lactamase-negative, ampicillin-resistant strains in many regions of the world is of substantial concern with treatment failure also being reported in response to macrolides [8][9][10] and fluoroquinolones [11][12][13].…”
Section: Introductionmentioning
confidence: 99%
“…It is characterized as serotype a to f based on polysaccharide capsule antigens and lack of a capsule are identified as nontypeable (NTHi). NTHi has been the most prevalent cause of community-acquired pneumonia and exacerbation of chronic obstructive pulmonary disease (COPD) (3,4). In addition, invasive diseases caused by NTHi are emerging globally and is predisposed by age and coexisting conditions (5).…”
Section: Introductionmentioning
confidence: 99%